Bio/Pharma Outsourcing Innovation 2023 eBook
Read the article:
Read the eBook:
News|Articles|February 15, 2023
- Pharmaceutical Technology, Bio/Pharma Outsourcing Innovation, February 2023
- Volume 2023 eBook
- Issue 1
- Pages: 22–28
Communication is Key in Complex Tech Transfer
Author(s)Susan Haigney
The complexity of the pharmaceutical product brings challenges to the transfer of information and technology between sponsors and contractors.
Advertisement
The relationship between pharmaceutical companies and the contract organizations that perform development and manufacturing services comes with the necessary process of transferring intellectual information, processes, and product from one organization to another. Complex products such as biologics and messenger RNA (mRNA) vaccines come with additional challenges during the tech transfer process.
To gain more insight on the complexities of transfer of pharmaceutical technology between contractors and sponsors, Pharmaceutical Technology® spoke with Petra Dieterich, scientific leader, and Jeffrey Mocny, scientific leader-Early Development, both with Abzena; Peter Ercoli, chief operating officer, Biologics, at BIOVECTRA; Deepak Thassu, PhD, MBA, senior vice president, R&D and Regulatory Submission, at LGM Pharma; Emma Rhodes, head of New Product Introduction at Sterling Pharma Solutions; Sara Schemel, senior process engineer, Dona York, principal process engineer, and Gauri Patki, senior process engineer, all at Catalent Biologics; Uwe Hanenberg, PhD, head of Product Development at Recipharm; and Rebecca Powell, associate director, Tech Transfer at Arranta Bio, a Recipharm company.
Article details
Pharmaceutical Technology
eBook: Bio/Pharma Outsourcing Innovation 2023
February 2023
Pages: 22–28
Citation
When referring to this article, please cite it as S. Haigney. Communication is Key in Complex Tech Transfer. Pharmaceutical Technology, Bio/Pharma Outsourcing Innovation eBook. 2023.
Articles in this issue
over 3 years ago
Preparing for a New Wave of mRNA Technologiesover 3 years ago
CROs Gaining a Competitive Edgeover 3 years ago
Biopharmaceutical Manufacturing Growthover 3 years ago
Forecasting Trends in Pharma Innovationover 3 years ago
Scaling Manufacturing Processes Using Single-Use TechnologiesAdvertisement
Related to this article
Ron Scarboro, Azurity Pharmaceuticals, explains how cross-functional development, disciplined reformulation, and post-approval metrics can help proven medicines work in everyday use.
This week, drug formulation and manufacturing experts showcased their knowledge, and companies exhibited their products, at CPHI Milan.
FDA approves Teva’s Weltruza, a once-monthly subcutaneous olanzapine for schizophrenia whose copolymer depot eliminates post-injection monitoring.
Mitigating nitrosamine risk requires assessing each product individually, says Bram Baert, Global Head of Regulatory Affairs at Capsugel, and Sandrine Picco, Senior Analytical Specialist on Capsugel's Innovaform Accelerator Team, in this interview with PharmTech.
Jason Bertola, executive director of Commercial Development for the Advanced Synthesis Platform at Lonza in North America, explains the demand for spray drying and the hurdles involved with scale up, in an interview with PharmTech.
The company is showcasing new development solutions and advanced digital technologies including its new OSD Express and Steriles Express solutions for drug development.
Ron Scarboro, Azurity Pharmaceuticals, explains when formulation robustness justifies added cost and which post-approval quality and supply metrics teams can track.
The winners of the CPHI Pharma Awards 2026 include a neurodegeneration platform, a track-and-trace packaging innovation, a enzymatic mRNA manufacturing technology, and a cell-free enzymatic biomanufacturing platform.
Advertisement
Advertisement